References
- Hoffman SL. Prevention of malaria. (Editorial) JAMA 1991: 265(3): 398–9
- Lackritz EM, Lobel HO, Howell BJ, et al. Imported Plasmodium falciparum malaria in American travelers to Africa: implications for prevention strategies. JAMA 1991: 265(3): 383–5
- Centers for Disease Control. Recommendations for the prevention of malaria among travelers. MMWR 1990: 39(RR3): 1–10
- Gardner P. Immunizations, medications, and common sense for the international traveler. Infect Dis Clin North Am 1990: 4(2): 179–97
- Mandell WF, Neu HC Parasitic infections: therapeutic considerations. Med Clin North Am 1988: 72(3): 669–90
- Drugs for parasitic infections. Med Lett Drugs Ther 1992: 34(865): 17–26
- Mefloquine for malaria. Med Lett Drugs Ther 1990: 31(811): 13–4
- Centers for Disease Control. Revised dosing regimen for malaria prophylaxis with mefloquine. MMWR 1990: 39(36): 630
- Rouveix B, Bricaire F, Michon C, et al. Mefloquine and an acute brain syndrome. (Letter) Ann Intern Med 1989: 110(7): 577–8
- Centers for Disease Control. Health information for international travel 1991. Atlanta: US Dept of Health and Human Services, 1991: 96–103; DHHS publication No.(CDC) 91; 8280
- Miller KD, Lobel HO, Satriale RF, et al. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trap Med Hyg 1986: 35(3): 451–8
- White NJ. Drug treatment and prevention of malaria. Eur J Clin Pharmacol 1988: 34(1): 1–14
- Johnson LW Preventive therapy for malaria. Am Fam Physician 1991: 44(2): 471–8
- Gordon DM. Malaria vaccines. Infect Dis Clin North Am 1990: 4(2): 299–313